Summary
Background In many cells, depletion of intracellular calcium (Ca 2+ ) reservoirs triggers Ca 2+ entry through store-operated Ca 2+ channels in the plasma membrane.
However, the mechanisms of agonist-induced calcium entry (ACE) in keratinocytes are not fully understood.
Objectives This study was designed to determine if pharmacological inhibition of calcium-independent phospholipase A (iPLA 2 ) impairs ACE in normal human epidermal keratinocytes. Methods Confocal laser scanning microscopy was used to monitor the dynamics of Ca 2+ signalling in keratinocytes loaded with the calcium-sensitive dye Fluo-4.
Cells were stimulated with extracellular nucleotides [adenosine triphosphate (ATP) or uridine triphosphate (UTP)] or with lysophosphatidic acid (LPA), a bioactive lipid that regulates keratinocyte proliferation and differentiation.
Results Both ATP and UTP induced Ca 2+ release in primary human keratinocytes. ) medium. Upon elevation of extracellular Ca 2+ to 1AE2 mmol L )1 , however, a biphasic response consisting of an initial Ca 2+ peak followed by an elevated plateau was observed. The plateau phase was inhibited when cells were treated with bromoenol lactone, a specific pharmacological inhibitor of iPLA 2 . These findings indicate that iPLA 2 activity is required for ACE in keratinocytes. LPA also evoked Ca 2+ release in keratinocytes but failed to induce sustained Ca 2+ entry even when extracellular Ca 2+ was elevated to 1AE2 mmol L ) 1 .
Conclusion
Our results demonstrate for the first time an important role for iPLA 2 in regulating ACE in primary human keratinocytes.
Calcium is a ubiquitous second messenger that regulates numerous cellular processes such as gene transcription, cell proliferation, exocytosis and contraction. 1 Free cytosolic calcium ([Ca 2+ ] i ) levels are tightly controlled by a complex network of receptors, channels and pumps located in the plasma membrane (PM) and on intracellular organelles such as the endoplasmic reticulum (ER), mitochondria and the Golgi apparatus. Stimulation of G protein-coupled receptors (GPCRs), tyrosine kinase receptors and nonreceptor tyrosine kinases activate phospholipase C (PLC) which in turn hydrolyses phosphatidylinositol 4,5-bisphosphate to diacylglycerol and inositol 1,4,5-trisphosphate (IP 3 ). 2 Binding of IP 3 to its receptors (IP 3 R) on the ER triggers the release of Ca 2+ from the ER lumen leading to store depletion. 1 In many cells, this initial release is followed by a sustained influx of Ca 2+ across the PM, a phenomenon known as store-operated calcium entry (SOCE), which is the dominant form of Ca 2+ entry in nonexcitable cells. 3 One model of SOCE involves a diffusible messenger or 'calcium influx factor' (CIF) that is released from the ER upon store depletion. 4 Although the identity of CIF is unknown, it appears to be a soluble factor of 600 Da that activates calcium-independent phospholipase A (iPLA 2 ) by displacement of inhibitory calmodulin (CaM) from iPLA 2 . 5 This leads to the production of lysophospholipids (lysoPLs) and free fatty acid. or by inhibition of the sarco-endoplasmic reticulum Ca 2+ -dissociate from STIM1 inducing the re-organization of STIM1 into discrete puncta. 6, 7 These complexes appear to associate with, and activate, the transmembrane protein Orai1, which appears to be the pore through which SOCE occurs. [8] [9] [10] [11] [12] Interestingly, STIM1 has also been reported to activate TRPC1, 13, 14 a member of the transient receptor potential (TRP) family of proteins which have been implicated in cation entry. 15 Little is known about the mechanisms of Ca 2+ entry in keratinocytes. A requirement for PLCc for SOCE has been demonstrated, 16 along with the formation of a ternary complex composed of PLCc, TRPC1 and IP 3 R. However, the putative role of iPLA 2 in Ca 2+ entry in keratinocytes has not been examined. In the present study therefore, we have investigated the role of iPLA 2 in agonist-induced Ca 2+ entry (ACE) in normal human epidermal keratinocytes (NHEKs). We have performed our studies using physiological agonists such as adenosine triphosphate (ATP) and uridine triphosphate (UTP), which have been reported to promote NHEK proliferation in vitro 17, 18 and lysophosphatidic acid (LPA, 1-acyl-sn-glycerol-3-phosphate), which can promote proliferation or differentiation depending on cell density. 19 These agonists are released by platelets recruited to the epidermis following injury, 17, 20 indicating a role in epidermal homeostasis. We found that the extracellular nucleotides but not LPA evoked sustained ACE in NHEK and that this was mediated at least in part by iPLA 2 .
Materials and methods

Reagents
Fluo-4-AM was purchased from Molecular Probes (Eugene, OR, U.S.A.), bromoenol lactone (BEL) from Sigma (Poole, Dorset, U.K.) and the iPLA 2 antibody from Santa Cruz (Santa Cruz, CA, U.S.A.). The iPLA 2 antibody recognizes iPLA2b but not iPLA 2 c according to the manufacturer. All other reagents were obtained from Sigma unless stated otherwise.
Cell culture
NHEK were prepared from redundant foreskin with the approval of the Newcastle and North Tyneside local ethical committee. The cells were cultured in supplemented MCDB 153 culture medium as previously described. 21 For imaging, cells were seeded at passage 1 or 2 in 20 lL suspensions containing 10 000-20 000 cells, with the medium increased to 1 mL about 45 min to 1 h after seeding. 
Calcium imaging
Western blotting
Primary keratinocyte lysates were separated on a 10% Bis-Tris gel (Invitrogen, Paisley, U.K.), transferred to a nitrocellulose membrane and incubated overnight with 10 lg mL )1 of iPLA 2 antibody (goat polyclonal, Santa Cruz). After extensive washing the membrane was probed with a biotinylated secondary antibody for 2-3 h, processed for chemiluminescence using ABC reagents (Vector Laboratories, Burlingame, CA, U.S.A.) and ECL Advance TM (GE Healthcare, Little Chalfont, U.K.), then visualized on a phosphoimager.
Statistical analysis
Results of the Ca 2+ imaging experiments are presented as means (± SEM) which were determined in GraphPad Prism (GraphPad Software, San Diego, CA, U.S.A.) or Microsoft Excel. Statistical significance was calculated using the unpaired two-tailed Student's t-test. A P-value < 0AE05 was considered significant. 23 Both UTP and ATP induced a biphasic response under these conditions, with a defined initial peak followed by an elevated plateau indicative of Ca 2+ entry (Fig. 2a,b) .
Results
Agonist-induced Ca
Taken together, these results indicate that the extracellular calcium ([Ca 2+ ] o ) level needs to be in the millimolar range before the electrochemical gradient is sufficiently high to promote robust ACE in keratinocytes following stimulation with exogenous nucleotides.
Inhibition of iPLA 2 impairs agonist-induced calcium entry in primary keratinocytes
A recent study by Bolotina and co-workers showed that pharmacological inhibition or RNAi knockdown of iPLA 2 impaired TG-induced entry in mouse smooth muscle cells. 4 Although the TG-induced SOCE has historically been considered as a mechanistic parallel of ACE, differences are beginning to emerge. 24 Figure 2a . In contrast, the elevated [Ca 2+ ] i phase was impaired in cells treated with BEL (Fig. 3a) , returning to baseline by 300 s in contrast to control cells. It is important to note that the control cells in Figure 3a were treated with dimethylsulphoxide which might explain why their responses differed somewhat to those in Figure 2a . Nevertheless, the data suggest that BEL treatment impairs Ca 2+ entry in NHEK.
Furthermore, similar results were obtained on the HaCaT keratinocyte cell line. 39 The expression of iPLA 2 in NHEK was assessed by Western blotting (Fig. 3c ). An 85-kDa band corresponding to the expected size of iPLA 2 was specifically detected in NHEK lysates probed with an antibody against iPLA 2 confirming that iPLA 2 is expressed in these cells. ity of LPA to evoke ACE in our experiments was not due to submaximal stimulation because dose-response curves revealed that LPA-mediated Ca 2+ release peaked at about 1 lmol L )1 (Fig. 4c) 5 Bolotina and colleagues recently demonstrated a role for lysoPLs iPLA 2 in TG-induced SOCE in rodent cells. 4 Our results extend their observations by showing that ACE in human keratinocytes also appears to be mediated at least in part by iPLA 2 . How does iPLA 2 mediate ACE? In the CIF-iPLA 2 model of SOCE, the lysoPLs generated by iPLA 2 are postulated to activate store-operated channels directly. 5 However, a ternary complex composed of PLCc, TRPC1 and IP 3 R has been detected in NHEKs. 16 Although the formation of the complex did not appear to be dependent on store depletion, knockdown of PLCc or TRPC1 (and TRPC4) suggested a role in Ca 2+ entry.
LPA-induced [Ca
Could iPLA 2 participate in the formation or localization of this complex? Recent evidence indicates that PLCc interacts with the TRPC3 to form a functional intermolecular pleckstrin homology (PH) domain that binds lipids 30 and that this enhances surface expression of TRPC3 in HEK293 cells. One possibility then is that lysoPLs generated by iPLA 2 enhance the localization of TRP proteins to the cell surface of keratinocytes, and that inhibition of iPLA 2 impairs this process. However, we cannot exclude a role for arachidonic acid generated by iPLA 2 activity, given that it has also been implicated in ACE 31 although this seems to occur only at submaximal agonist concentrations. Further investigations will be required to delineate the respective functions of lysoPLs and arachidonic acid in Ca 2+ entry in keratinocytes. 
